Cleerly LABS vs TeraRecon Cardiac.Chambers.MR
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Cleerly LABS provides comprehensive analysis of coronary CT angiography to detect and characterize atherosclerosis and stenosis in coronary arteries. In contrast, TeraRecon Cardiac.Chambers.MR specializes in the automatic segmentation and volumetric analysis of cardiac chambers from MR images. While both are FDA-cleared AI tools for cardiovascular imaging, they address distinct clinical needs using different imaging modalities.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Cleerly LABS is designed for comprehensive analysis of coronary CT angiography (CCTA) images to assess coronary artery disease. In contrast, TeraRecon Cardiac.Chambers.MR is an AI tool specifically for automatic segmentation of cardiac chambers from MR images.
Cleerly LABS offers AI-powered CCTA image analysis to detect, quantify, and characterize atherosclerosis and stenosis, including comprehensive coronary plaque assessment and ischemia detection with its ISCHEMIA module. TeraRecon Cardiac.Chambers.MR focuses on automatic segmentation of cardiac chambers (LV, RV) from MR images, providing volumetric analysis of ejection fraction and supporting MR flow analysis.
Cleerly LABS is priced 'per analysis,' with a retail price of $1500, often available at a discounted rate of $750, though the CCTA scan cost is separate and often out-of-pocket. TeraRecon Cardiac.Chambers.MR operates on a 'subscription-based' model, requiring one simple, annual fee for financial flexibility.
Cleerly LABS explicitly lists 'Tracking disease progression over time' as a key feature, aiding in personalized heart disease management. While TeraRecon Cardiac.Chambers.MR provides volumetric analysis of ejection fraction and segmentation, its features do not explicitly state tracking disease progression over time in the same manner.
Cleerly LABS provides quantitative measurements of coronary plaque volume and type, stenosis detection and quantification, and ischemia detection. TeraRecon Cardiac.Chambers.MR offers automatic segmentation of LV/RV inner and outer contours, volumetric analysis of ejection fraction, and supports AHA 17 segmentation model and MR flow analysis.
More Comparisons
Backers
Who funded each tool's parent company.